Desq Long
Sign in
SEC FORM 4
$180,691.89

Entrada Therapeutics, Inc. (TRDA)

Sale of 25,131 shares at $7.19 per share.

Reporting Persons MPM BioVentures 2014, L.P. · EVNIN LUKE · GADICKE ANSBERT · Foley Todd · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001231919-26-001143 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Entrada Therapeutics, Inc. (TRDA)." Disclosed 2026-09-03. https://desqlong.com/cards/0001231919-26-001143-2 (retrieved 2026-09-26).